FDA approves Alzheimerβs treatment that has been shown to slow decline in memory
2 July 2024 at 14:28
The FDA approved a new Alzheimerβs drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities.
Kisunla.
Β© Eli Lilly